Scientific Publications

Export 63 results:
Cantone MClaire, Ciocca M, Dionisi F, Fossati P, Lorentini S, Krengli M, Molinelli S, Orecchia R, Schwarz M, Veronese I et al..  2013.  Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy.. Radiat Oncol. 8(1):127.
Jereczek-Fossa BA, Bossi-Zanetti I, Mauro R, Beltramo G, Fariselli L, Bianchi LC, Fodor C, Fossati P, Baroni G, Orecchia R.  2013.  CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer : A prospective evaluation of 95 patients/118 lesions.. Strahlenther Onkol. 189(6):448-455.
Robert C, Dedes G, Battistoni G, Böhlen TT, Buvat I, Cerutti F, Chin MPW, Ferrari A, Gueth P, Kurz C et al..  2013.  Distributions of secondary particles in proton and carbon-ion therapy: a comparison between GATE/Geant4 and FLUKA Monte Carlo codes.. Phys Med Biol. 58(9):2879-99.
Molinelli S, Mairani A, Mirandola A, G Freixas V, Tessonnier T, Giordanengo S, Parodi K, Ciocca M, Orecchia R.  2013.  Dosimetric accuracy assessment of a treatment plan verification system for scanned proton beam radiotherapy: one-year experimental results and Monte Carlo analysis of the involved uncertainties.. Phys Med Biol. 58(11):3837-47.
Barazzuol L, Jena R, Burnet NG, Meira LB, Jeynes JCG, Kirkby KJ, Kirkby NF.  2013.  Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma.. Radiat Oncol. 8:65.
Rinaldi I, Brons S, Gordon J, Panse R, Voss B, Jäkel O, Parodi K.  2013.  Experimental characterization of a prototype detector system for carbon ion radiography and tomography.. Phys Med Biol. 58(3):413-27.
Habermehl D, Debus J, Ganten T, Ganten M-K, Bauer J, Brecht IC, Brons S, Haberer T, Haertig M, Jäkel O et al..  2013.  Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response.. Radiat Oncol. 8:59.
Bauer J, Unholtz D, Sommerer F, Kurz C, Haberer T, Herfarth K, Welzel T, Combs SE, Debus J, Parodi K.  2013.  Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment.. Radiother Oncol. 107(2):218-26.
Scifoni E, Tinganelli W, Weyrather WK, Durante M, Maier A, Krämer M.  2013.  Including oxygen enhancement ratio in ion beam treatment planning: model implementation and experimental verification.. Phys Med Biol. 58(11):3871-95.
Sánchez-Parcerisa D, Gemmel A, Jäkel O, Rietzel E, Parodi K.  2013.  Influence of the delta ray production threshold on water-to-air stopping power ratio calculations for carbon ion beam radiotherapy.. Phys Med Biol. 58(1):145-58.
Mairani A, Böhlen TT, Dokic I, Cabal G, Brons S, Haberer T.  2013.  Modelling of cell killing due to sparsely ionizing radiation in normoxic and hypoxic conditions and an extension to high LET radiation.. Int J Radiat Biol.
Mairani A, Böhlen TT, Schiavi A, Tessonnier T, Molinelli S, Brons S, Battistoni G, Parodi K, Patera V.  2013.  A Monte Carlo-based treatment planning tool for proton therapy.. Phys Med Biol. 58(8):2471-90.
Dosanjh M, Jones B, Myers S.  2013.  A possible biomedical facility at the European Organization for Nuclear Research (CERN).. Br J Radiol. 86(1025):20120660.
Ski ARuci, Bauer J, Campbell P, Brons S, Unholtz D, Habl G, Herfarth K, Debus J, Bert C, Parodi K et al..  2013.  Preclinical investigations towards the first spacer gel application in prostate cancer treatment during particle therapy at HIT.. Radiat Oncol. 8(1):134.
Orecchia R, Srivastava A, Fiore MRosaria, Vitolo V, Fossati P, Vischioni B, Iannalfi A, Tuan J, Ciocca M, Molinelli S et al..  2013.  Proton beam radiotherapy: report of the first patient treated at the Centro Nazionale di Adroterapia Oncologica (CNAO).. Tumori. 99(2):34e-7e.
Fattori G, Riboldi M, Desplanques M, Tagaste B, Pella A, Orecchia R, Baroni G.  2012.  Automated fiducial localization in CT images based on surface processing and geometrical prior knowledge for radiotherapy applications.. IEEE Trans Biomed Eng. 59(8):2191-9.
Holzscheiter MH, Bassler N, Dosanjh M, Sørensen BSingers, Overgaard J.  2012.  A community call for a dedicated radiobiological research facility to support particle beam cancer therapy.. Radiother Oncol. 105(1):1-3.
Kessel KA, Bougatf N, Bohn C, Habermehl D, Oetzel D, Bendl R, Engelmann U, Orecchia R, Fossati P, Pötter R et al..  2012.  Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework.. Radiat Oncol. 7:115.
Fossati P, Molinelli S, Matsufuji N, Ciocca M, Mirandola A, Mairani A, Mizoe J, Hasegawa A, Imai R, Kamada T et al..  2012.  Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy.. Phys Med Biol. 57(22):7543-54.
Dosanjh M, Cirilli M, Greco V, Meijer AE.  2012.  ENLIGHT: The European Network for Light Ion Hadron Therapy.. Health Phys. 103(5):674-80.
Hultqvist M, Lazzeroni M, Botvina A, Gudowska I, Sobolevsky N, Brahme A.  2012.  Evaluation of nuclear reaction cross-sections and fragment yields in carbon beams using the SHIELD-HIT Monte Carlo code. Comparison with experiments.. Phys Med Biol. 57(13):4369-85.
Sánchez-Parcerisa D, Gemmel A, Jäkel O, Parodi K, Rietzel E.  2012.  Experimental study of the water-to-air stopping power ratio of monoenergetic carbon ion beams for particle therapy.. Phys Med Biol. 57(11):3629-41.
Kurz C, Mairani A, Parodi K.  2012.  First experimental-based characterization of oxygen ion beam depth dose distributions at the Heidelberg Ion-Beam Therapy Center.. Phys Med Biol. 57(15):5017-34.
Grevillot L, Bertrand D, Dessy F, Freud N, Sarrut D.  2012.  GATE as a GEANT4-based Monte Carlo platform for the evaluation of proton pencil beam scanning treatment plans.. Phys Med Biol. 57(13):4223-44.
Barazzuol L, Jena R, Burnet NG, Jeynes JCG, Merchant MJ, Kirkby KJ, Kirkby NF.  2012.  In vitro evaluation of combined temozolomide and radiotherapy using X  rays and high-linear energy transfer radiation for glioblastoma.. Radiat Res. 177(5):651-62.


You are here